References
- Herwaldt BL. Leishmaniasis. Lancet 1999; 354: 1191–9.
- Dedet JP. Les leishmanioses: actualites. Presse Med 2000; 29: 1019–26.
- Davidson RN. Practical guide for treatment of leishmaniasis. Drugs 1998; 56: 1009–18.
- Laguna F, Adrados M, Alvar J, Soriano V, Valencia ME, Moreno V, et al. Visceral leishmaniasis in patients infected with the human immunodeficiency virus. Eur J Clin Microbiol Infect Dis 1997; 16: 898–903.
- Rosenthal E, Marty P, Le Fichoux Y, Cassuto JP. Clinical manifestations of visceral leishmaniasis associated with HIV infection: a retrospective study of 91 French cases. Ann Trop Med Parasitol 2000; 94: 37–42.
- WHO. Leishmania/HIV co-infection, south-western Europe, 1990–1998. Wkly Epidemiol Rec 1999; 74: 365–75.
- Rosenthal E, Marty P, Poizot-Martin I, Reynes J, Pratlong F, Lafeuillade A, et al. Visceral leishmaniasis in HIV-1 co-infection in southern France. Trans R Soc Trop Med Hyg 1995; 89: 159–62.
- WHO. Report on the consultative meeting on Leishmania/ HIV co-infection, 6–7 September, 1994, Rome. Geneva: WHO, WHO/LEISH/95.35/1995.
- Pesce A, Saint-Paul MC, Vinti H, Marty P, Taillan B, Le Fichoux Y, et al. Leishmaniose gastrique chez un malade atteint d’immunodéficience acquise. Presse Med 1990; 4: 178.
- Rosenthal E, Marty P, Pesce A. Leishmania in bronchoalveolar lavage. Ann Intern Med 1991; 114: 1064–5.
- Silva-Cardoso J, Moura B, Martins L, Mota-Miranda A, Rocha-Goncalves F, Lecour H. Pericardial involvement in human immunodeficiency virus infection. Chest 1999; 115: 418–22.
- Estok L, Wallach F. Cardiac tamponade in a patient with AIDS: a review of pericardial disease in patients with HIV infection. Mt Sinai J Med 1998; 65: 33–9.
- Chen Y, Brennessel D, Walters J, Johnson M, Rosner F, Raza M. Human immunodeficiency virus-associated pericardial effusion: Report of 40 cases and review of the literature. Am Heart J 1999; 137: 516–21.
- Longo-Mbenza B, Tonduangu K, Seghers KV, Mubagwa D. Irruption de l’infection par le VIH et des péricardites en Afrique. Arch Mal Cœur Vaiss 1997; 90: 1377–84.
- Berman JD. US Food and Drug Administration approval of AmBisome (liposomal amphotericin B) for treatment of visceral leishmaniasis. Clin Infect Dis 1999; 28 : 49–51.
- Sundar S, Goyal AK, More DK, Singh MK, Murray HW. Treatment of antimony-unresponsive Indian visceral leishmaniasis with ultra-short courses of amphotericin-B-lipid complex. Ann Trop Med Parasitol 1998; 92: 755–64.
- Jha TK, Sundar S, Thakur CP, Bachman P, Karbwang J, Fischer C, et al. Miltefosine, an oral agent, for treatment of Indian visceral leishmaniasis. N Engl J Med 1999; 341: 1795–800.